Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised trial of CSII versus MDI at diagnosis of type 1 diabetes in children and young people
2010-023792-25Phase 3Completed
- Sponsor
- Alder Hey Children's NHS Foundation Trust
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin glargine and insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Alder Hey Children's NHS Foundation Trust. Primary endpoint: Acceptability of randomisation to CSII or MDI at diagnosis (inbuilt pilot). Started Dec 2010; status: completed.
02
Drugs
insulin glargineinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2010-023792-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023792-25.